In Brief: Dornier Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Dornier Medical Systems: Pivotal clinical trial of the firm's Urowave microwave thermotherapy device for the treatment of benign prostatic hyperplasia shows 72% of 220 patients treated at five U.S. centers experienced a reduction in symptoms, the firm states in a release. "Treatment-related side effects were transient and not clinically significant," the firm notes. A premarket approval application for the device was filed in September...